LLC:ASXLendlease Group Analysis
Data as of 2026-06-17 - not real-time
A$2.93
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Lendlease Group trades at a **forward P/E of 5.78** versus an industry average of 32.39, with a **price‑to‑book of 0.36** and a **price‑to‑sales of 0.33**, suggesting a deep discount on valuation multiples. However, the company reports **negative operating and free cash flow**, a **gross margin of 7.9%**, and a **debt‑to‑equity ratio above 75%**, highlighting significant earnings and balance‑sheet pressures. The **dividend yield of 7.9%** appears attractive, but the **payout ratio of 47%** is being funded by cash reserves rather than earnings, raising sustainability concerns. Volatility over the past 30 days exceeds 45% and the beta is under 0.3, indicating the stock moves more sharply than the market while being relatively insulated from broader market swings.
Recent news of a **new CEO with capital‑markets expertise** and the continuation of a **$2.9 bn capital recycling program** have sparked a short‑term rally of over 4%, and the firm has reaffirmed guidance for its IDC segment. Technical indicators show the price is below the 20‑day (2.75) and 50‑day (3.04) SMAs, with a bearish trend direction, yet the MACD histogram turned positive, hinting at a possible early momentum shift. The stock sits near a support level of A$2.40 and faces resistance around A$3.08, making the next few weeks critical for confirming a sustainable recovery.
Recent news of a **new CEO with capital‑markets expertise** and the continuation of a **$2.9 bn capital recycling program** have sparked a short‑term rally of over 4%, and the firm has reaffirmed guidance for its IDC segment. Technical indicators show the price is below the 20‑day (2.75) and 50‑day (3.04) SMAs, with a bearish trend direction, yet the MACD histogram turned positive, hinting at a possible early momentum shift. The stock sits near a support level of A$2.40 and faces resistance around A$3.08, making the next few weeks critical for confirming a sustainable recovery.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support with bearish SMA positioning
- Positive MACD histogram suggesting possible short‑term bounce
- High volatility and decreasing volume trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- New CEO and capital recycling program addressing balance‑sheet strain
- Attractive valuation multiples relative to industry peers
- Maintained IDC segment guidance supporting earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential for debt reduction and cash‑flow improvement under new leadership
- Sustained dividend yield if earnings stabilize
- Diversified global asset base providing resilience
Key Metrics & Analysis
Financial Health
Revenue Growth-37.30%
Profit Margin-2.33%
P/E Ratio5.8
ROE-2.66%
ROA-0.10%
Debt/Equity75.51
P/B Ratio0.4
Op. Cash FlowA$-833000000
Free Cash FlowA$-811124992
Industry P/E32.4
Technical Analysis
TrendBearish
RSI54.3
SupportA$2.40
ResistanceA$3.08
MA 20A$2.75
MA 50A$3.04
MA 200A$4.42
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
Target PriceA$4.14
Upside/Downside41.44%
GradeUndervalued
TypeValue
Dividend Yield7.90%
Risk Assessment
Beta0.29
Volatility45.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.